Periodic Reporting for period 1 - CryoCLEMAV (Cryo-CLEM in situ imaging of adenovirus stepwise disassembly)
Período documentado: 2024-01-16 hasta 2026-01-15
A major part of the work was devoted to characterizing the entry pathway of adenoviruses into host cells. Using advanced fluorescence microscopy and complementary structural approaches, the project investigated the cellular mechanisms involved in viral entry and the intracellular trafficking of viral particles. These studies provided new insights into the molecular steps that govern adenovirus infection and its interaction with host cellular components.
In addition to these biological discoveries, the project contributed to the application of advanced imaging workflows integrating multiple microscopy techniques. These methodological approaches enabled the visualization of virus–host interactions with high spatial resolution and can be applied to study other viral systems and cellular processes.
Overall, the project generated new knowledge on virus–host interactions, particularly regarding adenovirus entry mechanisms. These findings represent an important contribution to the fields of virology, structural biology, and advanced microscopy.
One of the main contributions of the project is the characterization of the adenovirus entry pathway using complementary imaging approaches. While previous studies have described aspects of adenovirus infection, the integration of advanced microscopy techniques provides a more detailed view of the cellular processes involved in viral entry and intracellular trafficking.
Beyond the biological discoveries, the project also demonstrates the value of integrating multiple imaging techniques to study complex virus–host interactions. The methodological framework applied in the project provides new opportunities for investigating viral infection processes with high spatial resolution.
Further research may extend these approaches to other viral systems and explore the functional consequences of virus-induced genome reorganization. These advances may ultimately contribute to the development of new antiviral strategies and improved viral vector technologies.